Online pharmacy startup PharmEasy has closed a funding round worth nearly $350 million at a post-money valuation of $5.6 billion ahead of its initial public offering (IPO), reported The Economic Times. It raised nearly $204 million from marquee investors and $130-$140 million through secondary share sale. PharmEasy's Founders also bought shares worth $40 million in this funding round, it added.